Isodiol International Inc. Corporate Update

Isodiol provides a behind-the-scenes update on the Company’s progress made amid business disruption due to COVID-19. – Isodiol International Inc. (CSE:ISOL) (CNSX:ISOL.CN) (OTC:ISOLF) (FSE:LB6B.F) (the “Company” or “Isodiol”) is completing the final stage of restructuring from a traditional business model to an agile, global online sales, research and development company. From executive staff to remote support, Isodiol has navigatedContinue reading “Isodiol International Inc. Corporate Update”

Isodiol International Inc. Corporate Update

Isodiol provides a behind-the-scenes update on the Company’s progress made amid business disruption due to COVID-19. – Isodiol International Inc. (CSE:ISOL) (CNSX:ISOL.CN) (OTC:ISOLF) (FSE:LB6B.F) (the “Company” or “Isodiol”) is completing the final stage of restructuring from a traditional business model to an agile, global online sales, research and development company. From executive staff to remote support, Isodiol has navigatedContinue reading “Isodiol International Inc. Corporate Update”

Emerald Health Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update

 – September 1, 2020) – Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (“Emerald”) reported financial results for the three and six months ended June 30, 2020. Full versions of the Company’s unaudited condensed interim consolidated financial statements and MD&A can be found on SEDAR at www.sedar.com. “The second quarter was a very solid quarter in allContinue reading “Emerald Health Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update”

EnWave Announces 2020 Third Quarter Consolidated Interim Financial Results and Corporate Strategy Update

#ENW Highlights for Q3 Revenue from EnWave in Q3 2020 was $1,609 (expressed in ‘000s) compared to $5,075 in Q3 2019, a decrease of $3,466 or 68%. The decrease in revenue was due to a slowdown in large-scale Radiant Energy Vacuum (“REVTM”) machinery sales primarily to cannabis royalty partners. Reduced company-wide overhead expenses by $1.0Continue reading “EnWave Announces 2020 Third Quarter Consolidated Interim Financial Results and Corporate Strategy Update”

The Green Organic Dutchman Provides Corporate Update and Confirms Product Innovation Pipeline Expansion

Launching Highly Dutch across Canada in the second half of September Bringing innovative products to market, including expanded RIPPLE suite of products Appointed new head of operations Signed distribution agreements for international exports to Australia/NZ – The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX: TGOD) (US: TGODF), a leading producer of premium certified organically grown cannabis,Continue reading “The Green Organic Dutchman Provides Corporate Update and Confirms Product Innovation Pipeline Expansion”

Yield Growth Announces Name Change and Provides Corporate Update

 – August 13, 2020) –  The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) (the “Company“) announces that it will be changing its corporate name to Better Plant Sciences Inc. to reflect its strategic focus on the fast-growing market for plant-based consumer products. The Company’s new stock symbol on the CSE will be “PLNT“, and the name changeContinue reading “Yield Growth Announces Name Change and Provides Corporate Update”

Indiva Extends Maturity of Senior Debt to October 2021

Provides Q2 Revenue Guidance and Corporate Update — Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (OTCQX:NDVAF) is pleased to announce its senior lender has extended the maturity of the Company’s senior secured demand loan and factoring agreement (the terms of which are discussed in the Company’s press release dated October 15, 2019) until October 31,Continue reading “Indiva Extends Maturity of Senior Debt to October 2021”

Zenabis Provides Corporate Update

– Zenabis Global Inc. (TSX: ZENA) (“Zenabis” or the “Company“) today provided a corporate update on its recent activities. Highlights The Company has entered into multiple international supply arrangements and expects to ship 550 kg of dried cannabis in July and August under these arrangements. Ongoing demand under these arrangements is expected to be 750 kg perContinue reading “Zenabis Provides Corporate Update”

Khiron Provides Corporate Update: Surpasses 1,000 Medical Cannabis Patient Prescription Milestone

Company surpasses 1,000 medical cannabis patient prescriptions in Colombia in the first 10 weeks of sales activity, representing a milestone towards meeting patient needs in Latin America and globally Company prudently managing financial resources through reduced expenses and held approximately $20 Million in cash at the end of June 2020, after closing Q1 with $24 Million and Q4 2019 with $36 Million Received authorization forContinue reading “Khiron Provides Corporate Update: Surpasses 1,000 Medical Cannabis Patient Prescription Milestone”